Taewoong Choi
Advanced in Angioimmunoblastic T-cell Lymphoma

Dr. Taewoong Choi

Hematology Oncology | Hematology | Transplant Surgery
Duke Health
Duke Blood Cancer Center
2400 Pratt St, 
Durham, NC 
On Staff At
Accepting New Patients
Offers Telehealth

Advanced in Angioimmunoblastic T-cell Lymphoma
Duke Health
Duke Blood Cancer Center
2400 Pratt St, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients.

Dr. Choi is rated as an Advanced provider by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Seoul National University (South Korea)
Specialties
Hematology Oncology
Hematology
Transplant Surgery
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Internal Med, Internal Medicine
American Board Of Internal Med, Medical Oncology
American Board Of Internal Med, Hematology
Fellowships
Hematology/Oncology Fellowship Program, UPMC (Pittsburgh, PA), BMT Fellowship Program, Stanford (Stanford, CA)
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
Korean
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Duke Blood Cancer Center
2400 Pratt St, Durham, NC 27705
Call: 919-684-8964

Additional Areas of Focus

Dr. Choi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

POEMS Syndrome
Multiple Myeloma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Lenalidomide, Daratumumab/rHuPH20
Study Phase: Phase 3

25 Total Publications

Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study.
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study.
Journal: Transplantation and cellular therapy
Published: June 27, 2025
View All 25 Publications
Similar Doctors
Jie Wang
Advanced in Angioimmunoblastic T-cell Lymphoma
Dr. Jie Wang
Hematology Oncology | Hematology
Advanced in Angioimmunoblastic T-cell Lymphoma
Dr. Jie Wang
Hematology Oncology | Hematology

Duke Blood Cancer Center

2400 Pratt St, 
Durham, NC 
 (0.1 miles away)
919-684-8964
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

I care for patients who are diagnosed with lymphoma. I am really passionate about my work because our scientific understanding of lymphoma is rapidly increasing. This new knowledge is helping us care for our patients better. I strive to understand my patients, both how they feel physically and emotionally. I aim to guide my patients through the best treatment options for them. These choices may include new treatments and clinical trials. I always try to treat my patients like my own family. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

Richard D. Lopez
Advanced in Angioimmunoblastic T-cell Lymphoma
Dr. Richard D. Lopez
Hematology Oncology | Transplant Surgery
Advanced in Angioimmunoblastic T-cell Lymphoma
Dr. Richard D. Lopez
Hematology Oncology | Transplant Surgery

Duke Adult Blood And Marrow Transplant Clinic

2400 Pratt St, 
Durham, NC 
 (0.1 miles away)
919-668-1002
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Lopez is a Hematologist Oncology specialist and a Transplant Surgeon in Durham, North Carolina. Dr. Lopez is rated as an Advanced provider by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Lopez is currently accepting new patients.

Alexandra Stefanovic
Advanced in Angioimmunoblastic T-cell Lymphoma
Dr. Alexandra Stefanovic
Hematology Oncology | Hematology
Advanced in Angioimmunoblastic T-cell Lymphoma
Dr. Alexandra Stefanovic
Hematology Oncology | Hematology

Duke Blood Cancer Center

2400 Pratt St, 
Durham, NC 
 (0.1 miles away)
919-684-8964
Languages Spoken:
English, French, German, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. Her top areas of expertise are Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.

VIEW MORE ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Choi's expertise for a condition
ConditionClose
    • Distinguished
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
      Dr. Choi is
      Distinguished
      . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
      See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
    • Multiple Myeloma
      Dr. Choi is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Smoldering Multiple Myeloma
      Dr. Choi is
      Distinguished
      . Learn about Smoldering Multiple Myeloma.
      See more Smoldering Multiple Myeloma experts
    • Advanced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Choi is
      Advanced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Choi is
      Advanced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Choi is
      Advanced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Angioimmunoblastic T-cell Lymphoma
      Dr. Choi is
      Advanced
      . Learn about Angioimmunoblastic T-cell Lymphoma.
      See more Angioimmunoblastic T-cell Lymphoma experts
    • Bone Marrow Transplant
      Dr. Choi is
      Advanced
      . Learn about Bone Marrow Transplant.
      See more Bone Marrow Transplant experts
    • Castleman Disease
      Dr. Choi is
      Advanced
      . Learn about Castleman Disease.
      See more Castleman Disease experts
    View All 33 Advanced Conditions
    • Experienced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Choi is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Mountain Sickness
      Dr. Choi is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Promyelocytic Leukemia
      Dr. Choi is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Agranulocytosis
      Dr. Choi is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anaplastic Large Cell Lymphoma
      Dr. Choi is
      Experienced
      . Learn about Anaplastic Large Cell Lymphoma.
      See more Anaplastic Large Cell Lymphoma experts
    • Aplastic Anemia
      Dr. Choi is
      Experienced
      . Learn about Aplastic Anemia.
      See more Aplastic Anemia experts
    View All 52 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.